These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19286424)

  • 1. Serotonin and pulmonary hypertension--from bench to bedside?
    MacLean MR; Dempsie Y
    Curr Opin Pharmacol; 2009 Jun; 9(3):281-6. PubMed ID: 19286424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension and the serotonin hypothesis: where are we now?
    MacLean MR
    Int J Clin Pract Suppl; 2007 Sep; (156):27-31. PubMed ID: 17663674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serotonin hypothesis and pulmonary artery hypertension].
    Kloza M; Baranowska-Kuczko M; Pędzińska-Betiuk A; Jackowski K; Kozłowska H
    Postepy Hig Med Dosw (Online); 2014 Jun; 68():738-48. PubMed ID: 24934532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia.
    Eddahibi S; Guignabert C; Barlier-Mur AM; Dewachter L; Fadel E; Dartevelle P; Humbert M; Simonneau G; Hanoun N; Saurini F; Hamon M; Adnot S
    Circulation; 2006 Apr; 113(15):1857-64. PubMed ID: 16606791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.
    White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR
    Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension: therapeutic targets within the serotonin system.
    Dempsie Y; MacLean MR
    Br J Pharmacol; 2008 Oct; 155(4):455-62. PubMed ID: 18536742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin Signaling Through the 5-HT
    Hood KY; Mair KM; Harvey AP; Montezano AC; Touyz RM; MacLean MR
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1361-1370. PubMed ID: 28473438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serotonin hypothesis of pulmonary hypertension revisited.
    Maclean MR; Dempsie Y
    Adv Exp Med Biol; 2010; 661():309-22. PubMed ID: 20204739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serotonin receptor and transporter as potential therapeutic targets for pulmonary hypertension.
    Wang HL
    Curr Opin Investig Drugs; 2004 Sep; 5(9):963-6. PubMed ID: 15503652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine attenuates chronic methamphetamine-induced pulmonary arterial remodelling: possible involvement of serotonin transporter and serotonin 1B receptor.
    Liu M; Wang Y; Wang HM; Bai Y; Zhang XH; Sun YX; Wang HL
    Basic Clin Pharmacol Toxicol; 2013 Feb; 112(2):77-82. PubMed ID: 22900600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From functional to genetic studies of a candidate gene for pulmonary hypertension: Any point?
    Eddahibi S; Adnot S
    Am J Respir Crit Care Med; 2006 Apr; 173(7):693-4. PubMed ID: 16556698
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular and molecular pathobiology of pulmonary arterial hypertension.
    Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho.
    MacLean MR; Fanburg B; Hill N; Lazarus HM; Pack TF; Palacios M; Penumatsa KC; Wring SA
    Compr Physiol; 2022 Aug; 12(4):4103-4118. PubMed ID: 36036567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serotonin pathway in pulmonary hypertension.
    Eddahibi S; Adnot S
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):621-5. PubMed ID: 16878724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the serotonin transporter protein (SERT) gene in patients with pulmonary arterial hypertension.
    Baloira A; Núñez M; Cifrian J; Vilariño C; Ojeda M; Valverde D
    Arch Bronconeumol; 2012 Mar; 48(3):77-80. PubMed ID: 22177971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension.
    Dempsie Y; MacRitchie NA; White K; Morecroft I; Wright AF; Nilsen M; Loughlin L; Mair KM; MacLean MR
    Cardiovasc Res; 2013 Jul; 99(1):24-34. PubMed ID: 23519266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension.
    Rothman RB; Cadet JL; Dersch CM; McCoy MT; Lehrmann E; Becker KG; Bader M; Alenina N; Baumann MH
    PLoS One; 2011 Mar; 6(3):e17735. PubMed ID: 21464983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.
    Dempsie Y; Morecroft I; Welsh DJ; MacRitchie NA; Herold N; Loughlin L; Nilsen M; Peacock AJ; Harmar A; Bader M; MacLean MR
    Circulation; 2008 Jun; 117(22):2928-37. PubMed ID: 18506000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serotonin transporter (SERT) gene polymorphism and idiopathic pulmonary arterial hypertension: a meta-analysis and review of the literature.
    Zhang H; Xu M; Xia J; Qin RY
    Metabolism; 2013 Dec; 62(12):1867-75. PubMed ID: 24075737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension.
    Morecroft I; White K; Caruso P; Nilsen M; Loughlin L; Alba R; Reynolds PN; Danilov SM; Baker AH; Maclean MR
    Mol Ther; 2012 Aug; 20(8):1516-28. PubMed ID: 22525513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.